Kawakami, Yutaka
Ohta, Shigeki
Sayem, Mohammad A.
Tsukamoto, Nobuo
Yaguchi, Tomonori
Article History
Received: 2 December 2019
Accepted: 23 December 2019
First Online: 9 January 2020
Compliance with ethical standards
:
: Y. Kawakami is an advisor for Taiho Pharma Co. Ltd., has received honoraria from Ono Pharmaceutical Co. Ltd., Bristol-Myers Squibb, MSD, Chugai, AstraZeneca, and has received research funding from Ono Pharmaceutical Co. Ltd., Bristol-Myers Squibb, Kowa, JSR, Dainippon Sumitomo Pharma Co. Ltd., and Carna BioSciences, Inc. Other co-authors have no conflict of interest.
: The authors comply with the ethical standards of the journal.
: All of the authors’ studies with human participants are approved by the Keio University ethics committee and appropriately performed.